Maria del Mar Riveiro Barciela

Institutions of which they are part

Main researcher
Liver Diseases

Vall Hebron Institut de Recerca

Maria del Mar Riveiro Barciela

Institutions of which they are part

Main researcher
Liver Diseases

Vall Hebron Institut de Recerca

Projects

Análisis de situación y estrategia de manejo de pacientes con infección crónica por VHB sin criterios de tratamiento según las guías de la Asociación Europea para el estudio del hígado

IP: Maria Buti Ferret
Collaborators: Maria del Mar Riveiro Barciela
Funding agency: Gilead Sciences, S.L.U.
Funding: 39591
Reference: GLD13/00137
Duration: 18/09/2013 - 17/09/2014

Investigación clínica y traslacional en enfermedades hepáticas.

IP: -
Collaborators: Maria del Mar Riveiro Barciela
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM13/00158
Duration: 01/04/2014 - 31/03/2016

Related news

Vall d’Hebron participates in a consensus to optimize equity in access to liver transplant

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.